Role of Naturally Occurring CD4+CD25+ Regulatory T Cells in Experimental Atherosclerosis
暂无分享,去创建一个
G. Keren | A. Afek | G. Luboshits | D. Planer | J. George | S. Metzger | A. Mor | T. Chajek‐Shaul
[1] G. Keren,et al. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. , 2006, European heart journal.
[2] R. Flavell,et al. Natural regulatory T cells control the development of atherosclerosis in mice , 2006, Nature Medicine.
[3] G. Keren,et al. Altered status of CD 4 1 CD 25 1 regulatory T cells in patients with acute coronary syndromes , 2006 .
[4] L. A. Stephens,et al. Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.
[5] S. Ziegler,et al. FOXP3 acts as a rheostat of the immune response , 2005, Immunological reviews.
[6] M. Peakman,et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. , 2005, Diabetes.
[7] A. O’Garra,et al. Regulatory T cells and mechanisms of immune system control , 2004, Nature Medicine.
[8] C. Piccirillo,et al. Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. , 2004, Trends in immunology.
[9] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[10] Y. Shoenfeld,et al. Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I. , 2004, Cardiovascular research.
[11] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[12] C. Baecher-Allan,et al. Human CD4+CD25+ regulatory T cells. , 2004, Seminars in immunology.
[13] S. Sakaguchi. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.
[14] L. Chatenoud,et al. Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Witztum,et al. Oxidized low density lipoprotein and innate immune receptors , 2003, Current opinion in lipidology.
[16] S. Rubin,et al. Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly: Findings From the Health, Aging, and Body Composition Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[17] H. Ochs,et al. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.
[18] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[19] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[20] C. Baecher-Allan,et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis , 2003, European journal of immunology.
[21] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[22] J. Witztum,et al. Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.
[23] Jacob George,et al. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. , 2002, Journal of the American College of Cardiology.
[24] P. Libby,et al. Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice , 2002, Circulation.
[25] Lei Zhao,et al. 12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient Mice , 2001, Circulation.
[26] Y. Shoenfeld,et al. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. , 2001, Journal of the American College of Cardiology.
[27] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[28] M. Roncarolo,et al. Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.
[29] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[30] D. Galas,et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.
[31] Xinghua Zhou,et al. Transfer of CD4+ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice , 2000, Circulation.
[32] Y. Shoenfeld,et al. Adoptive Transfer of β2-Glycoprotein I–Reactive Lymphocytes Enhances Early Atherosclerosis in LDL Receptor–Deficient Mice , 2000 .
[33] H. Weiner,et al. Oral Administration of Myelin Induces Antigen‐specific TGF‐β1 Secreting T Cells in Patients with Multiple Sclerosis a , 1997, Annals of the New York Academy of Sciences.
[34] G. Hansson,et al. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.
[35] H. Weiner,et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.
[36] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.